The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEden Regulatory News (EDEN)

Share Price Information for Eden (EDEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.50
Ask: 5.00
Change: 0.00 (0.00%)
Spread: 0.50 (11.111%)
Open: 4.75
High: 4.75
Low: 4.75
Prev. Close: 4.85
EDEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Data Access Licence and Royalty Agreement

13 Jan 2014 07:00

RNS Number : 4441X
Eden Research plc
13 January 2014
 



 

Eden Research Plc

("Eden" or "Company")

 

Data Access Licence and Royalty Agreement

 

Eden Research plc (AIM: EDEN), the AIM listed natural micro-encapsulation company, announces that it has granted access to its EU regulatory data and dossiers to Desarrollo Agricola y Minero S.A. ("Daymsa") of Zaragoza, Spain.

 

In 2013, Eden received approval for three active substances under the European Union Regulation ("EC") No. 1107/2009 concerning the Placing of Plant Protection Products on the Market. This data, which was generated by Eden to register its own plant protection product 3AEY, is also of value to third parties as a basis to register their own products using one or more of the same active substances.

 

Daymsa already uses similar natural ingredients in its existing product portfolio and shall now register new products using the data for the active substances registered by Eden.

 

Clive Newitt, Managing Director of Eden comments: "Having invested a considerable amount of time, money and effort into the EU approvals of the three active substances, it is pleasing to see a return on our investment through upfront and milestone payments, as well as royalties on commercial sales. Daymsa is a well-established business with presence in Europe and Latin America and so the potential reach of these new products is significant."

 

Juan Pardos, General Manager of Daymsa comments: "Daymsa, a leading producer in Europe of Leonardite, is a 34 year old Spanish company that specialized in "Bio-stimulant and Bio-control products" even before those terms became of general use in ecological and conventional agriculture. This strategic agreement with Eden will enable us to become a leading company in Europe not only as leading producer of Leonardite but also a leading producer of "Vegetable Extract based" Bio-Control products."

 

Enquiries:

 

Eden Research plc

www.edenresearch.com

Clive Newitt, Managing Director

Tel: 01993 862 761

Alex Abrey, Chief Financial Officer

W H Ireland Limited

Tel: 0117 945 3471

John Wakefield

Walbrook PR Ltd

Tel: 020 7933 8780 or eden@walbrookpr.com

Paul McManus (Media Relations)

Mob: 07980 541 893

Paul Cornelius (Investor Relations)

Mob: 07827 879 496

 

 

 

 

Notes:

 

Eden is an early stage revenue company with intellectual property and expertise in encapsulation, terpenes and environmentally friendly technologies to provide naturally occurring solutions to the global agrochemicals industry, the animal health industry, and consumer products.

 

Eden's encapsulation technology harnesses the biocidal efficacy of naturally occurring chemicals produced by plants (terpenes) and can also be used with hydrophobic compounds both natural and synthetic. The technology uses yeast cells to deliver a slow release of natural compounds for agricultural and non-agricultural uses. Terpenes are already widely used in the food flavouring, cosmetic and pharmaceutical industries.

 

Historically, terpenes have had limited commercial use in the agrochemical sector due to their volatility, phytotoxicity and poor solubility. Eden's platform encapsulation technology provides a unique, environmentally friendly solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

 

With leading consultants in their respective fields, the Company is developing these technologies through innovative research and a series of commercial production, marketing and distribution partnerships.

 

The Company has a number of patents and has a pipeline of products at differing stages of development targeting specific areas of the global agrochemicals industry. To date, the Company has invested in the region of £12m in developing and protecting its intellectual property. Revenues earned by the Company have been modest whilst the Company has concentrated on securing patent protection for its intellectual property, identifying suitable industrial partners and entering into licence agreements.

 

Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN.

 

For more information about Eden, please visit www.edenresearch.com

  

 

 

 

 

Daymsa, Europe´s leading producer of Leonardite started producing Leonardite based soil amendment products as early as in 1979. Since that time our investment in Quality and Sustainable Agriculture has been strengthened with the development of a full range of Bio-stimulant and Bio-control Products.

 

The increase in the world's population, a higher percentage of the world population entering the consumer market and the harsh competition of the Bio-Fuels over the limited land resources compelled Bio-technological companies like Daymsa to force their Research and Development departments into the search for solutions that can help to increase the world production of food, maintaining and increasing the long term quality and richness of the land.

 

The Sustainable Agriculture Solutions of Daymsa include a full range of

a) Soil and water conditioners

b) Bio-stimulants

c) Bio-control Products

d) Specialized microelement deficiency amendments

 

The actual Biocontrol portfolio products of Daymsa is based on the broad experience of Daymsa and its three subsidiary companies established in Brazil, Colombia and Ecuador not only in the European and Southern American market but also in the Middle East and North American countries. The Strategical Agreement signed with Eden will allow Daymsa to become one of the first producer of very effective Plant Protection Products based on Plant Extracts Registered in Europe.

 

For more information about Daymsa, please visit www.daymsa.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRGGUPCGUPCGQP
Date   Source Headline
24th Sep 20187:00 amRNSHalf-year Report
13th Jul 201810:23 amRNSDirector/PDMR Shareholding
21st Jun 20184:44 pmRNSResult of AGM
21st Jun 20187:00 amRNSAGM Statement
19th Jun 20187:00 amRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSRegulatory Progress Update
30th May 20182:30 pmRNSPosting of Annual Report & Notice of AGM
10th May 20185:04 pmRNSDirector/PDMR Shareholding
8th May 20187:00 amRNSExercise of Options
20th Mar 20187:00 amRNSPreliminary results
11th Jan 20187:00 amRNSYear-end Trading Statement
12th Dec 20177:00 amRNSRegulatory Progress Update
29th Sep 201711:15 amRNSHalf-year Report - Replacement
29th Sep 20177:30 amRNSAdoption of New LTIP and Grant of Awards
29th Sep 20177:01 amRNSBoard Changes
29th Sep 20177:00 amRNSHalf-year Report
25th Sep 20177:00 amRNSApproval of MevaloneT in Portugal
1st Sep 20177:00 amRNSNotice of Results
30th Jun 20175:14 pmRNSHolding(s) in Company
30th Jun 201712:29 pmRNSResult of AGM
30th Jun 20177:43 amRNSAGM Statement
30th Jun 20177:39 amRNSCompletion of Placing & Subscription
30th Jun 20177:00 amRNSSipcam agreements, investment and proposed placing
29th Jun 20179:43 amRNSNew terms agreed with UMMS
5th Jun 20173:14 pmRNSPosting of Annual Report & Notice of AGM
22nd May 20177:00 amRNSFinal Results
11th May 20179:00 amRNSEden Research on BBC Radio 4's You & Yours
29th Mar 20177:00 amRNSExtension of patent protection in Greece
8th Mar 20172:40 pmRNSVoting Rights, Warrants and Options Outstanding
23rd Jan 20172:00 pmRNSPrice Monitoring Extension
23rd Jan 20177:00 amRNSFungicide product approved for sale in France
21st Dec 20167:01 amRNSTrading update
21st Dec 20167:00 amRNSEastman commercialisation agreement for nematicide
27th Sep 20167:00 amRNSHalf-year Report
28th Jun 201612:28 pmRNSResult of AGM
28th Jun 20167:00 amRNSAGM Statement
15th Jun 20167:00 amRNSLabel extensions for 3AEY in Spain and Greece
7th Jun 20167:00 amRNSPosting of Annual Report & Notice of AGM
26th May 20163:36 pmRNSDirector/PDMR Shareholding
24th May 20167:00 amRNSFinal Results
11th Apr 20169:31 amRNSHolding(s) in Company
30th Mar 20167:00 amRNSPlacing to raise £2.6m
22nd Feb 20167:00 amRNSApproval of 3AEY in Spain
11th Feb 20167:00 amRNSApproval of 3AEY in Italy
10th Feb 20167:00 amRNSFirst shipment of MevaloneT (3AEY) to Greece
21st Jan 20167:00 amRNSExercise of options
14th Jan 20167:00 amRNSFurther progress with EU product approvals
16th Nov 20157:00 amRNSKenya approval & first commercial-scale order
26th Oct 20157:00 amRNSAppointment of Nominated Adviser and Broker
24th Sep 20157:00 amRNSCollaboration and Licence Agreement Signed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.